Tanaka Y - Search Results

1

Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.

Yamauchi J, Coler-Reilly A, Sato T, Araya N, Yagishita N, Ando H, Kunitomo Y, Takahashi K, Tanaka Y, Shibagaki Y, Nishioka K, Nakajima T, Hasegawa Y, Utsunomiya A, Kimura K, Yamano Y. Yamauchi J, et al. Among authors: tanaka y. J Infect Dis. 2015 Jan 15;211(2):238-48. doi: 10.1093/infdis/jiu438. Epub 2014 Aug 7. J Infect Dis. 2015. PMID: 25104771

2

Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M. Moritoyo T, et al. Among authors: tanaka y. J Neurovirol. 1999 Jun;5(3):241-8. doi: 10.3109/13550289909015810. J Neurovirol. 1999. PMID: 10414514

3

Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.

Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR. Hanon E, et al. Among authors: tanaka y. Blood. 2000 Feb 15;95(4):1386-92. Blood. 2000. PMID: 10666215 Free article.

4

Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.

Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, Izumo S, Osame M. Furukawa Y, et al. Among authors: tanaka y. J Infect Dis. 2003 Apr 1;187(7):1116-25. doi: 10.1086/368379. Epub 2003 Mar 13. J Infect Dis. 2003. PMID: 12660926

5

Potential immunogenicity of adult T cell leukemia cells in vivo.

Kurihara K, Harashima N, Hanabuchi S, Masuda M, Utsunomiya A, Tanosaki R, Tomonaga M, Ohashi T, Hasegawa A, Masuda T, Okamura J, Tanaka Y, Kannagi M. Kurihara K, et al. Among authors: tanaka y. Int J Cancer. 2005 Mar 20;114(2):257-67. doi: 10.1002/ijc.20737. Int J Cancer. 2005. PMID: 15551352

6

A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load.

Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor GP, Bangham CRM. Asquith B, et al. Among authors: tanaka y. J Gen Virol. 2005 May;86(Pt 5):1515-1523. doi: 10.1099/vir.0.80766-0. J Gen Virol. 2005. PMID: 15831965

7

Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.

Kondo K, Okuma K, Tanaka R, Zhang LF, Kodama A, Takahashi Y, Yamamoto N, Ansari AA, Tanaka Y. Kondo K, et al. Among authors: tanaka r, tanaka y. Hum Immunol. 2007 Jul;68(7):563-71. doi: 10.1016/j.humimm.2007.03.012. Epub 2007 Apr 13. Hum Immunol. 2007. PMID: 17584577

8

Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.

Okuma K, Tanaka R, Ogura T, Ito M, Kumakura S, Yanaka M, Nishizawa M, Sugiura W, Yamamoto N, Tanaka Y. Okuma K, et al. Among authors: tanaka r, tanaka y. J Infect Dis. 2008 Jan 1;197(1):134-41. doi: 10.1086/524303. J Infect Dis. 2008. PMID: 18171296

9

Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.

Nose H, Kubota R, Seth NP, Goon PK, Tanaka Y, Izumo S, Usuku K, Ohara Y, Wucherpfennig KW, Bangham CR, Osame M, Saito M. Nose H, et al. Among authors: tanaka y. J Infect Dis. 2007 Dec 15;196(12):1761-72. doi: 10.1086/522966. J Infect Dis. 2007. PMID: 18190256 Free PMC article.

10

Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.

Abdelbary NH, Abdullah HM, Matsuzaki T, Hayashi D, Tanaka Y, Takashima H, Izumo S, Kubota R. Abdelbary NH, et al. Among authors: tanaka y. J Infect Dis. 2011 Apr 1;203(7):948-59. doi: 10.1093/infdis/jiq153. J Infect Dis. 2011. PMID: 21402546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,310 results

Search Page

Filters